Obturator Nerve Block in Patients With Hip Fracture

• Register: ClinicalTrials.gov
• Last refreshed on: 21 September 2015
• Main ID: NCT02408419
• Date of registration: 31/03/2015
• Prospective Registration: No
• Primary sponsor: University of Aarhus
• Public title: Obturator Nerve Block in Patients With Hip Fracture OPAD
• Scientific title: Proximal Obturator Nerve Block After Insufficient Analgesic Effect of Femoral Nerve Block in Patients With Hip Fracture
• Date of first enrolment: March 2015
• Target sample size: 0
• Recruitment status: Withdrawn
• URL: https://clinicaltrials.gov/show/NCT02408419
• Study type: Interventional
• Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
• Phase: Phase 4

Countries of recruitment

Denmark

Contacts

• Name: Thomas F. Bendtsen, MD, Ph.d.
• Affiliation: Aarhus University Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- Clinical suspicion of hip fracture

- Successful sensory cutaneous effect of the femoral nerve block

- Age = 55 years

- Mentally capable of comprehending and using verbal pain score

- Mentally capable of differentiating between pain from the fractured hip and pain from
other locations

- Mentally capable of understanding the given information

- Arrival in the emergency room at times when one of the doctors who do the nerve
blocks for this investigation are on call

- Possible sonographic visualization of the structures needed for the nerve block

- Verbal numeric pain scale score (NRS 0-10) > 5 with passive leg raise of the
fractured leg at the time of inclusion OR NRS > 3 at rest, 30 minutes after a femoral
nerve block

- Patients informed consent

Exclusion Criteria:

- Hip fracture not confirmed by x-ray

- Weight < 45 kg

- Patient has previously been included in this trial

- If the patient wishes to be excluded

- Allergy to local anesthetics or adrenocortical hormone

- Visible infection in the area of the point of needle injection



Age minimum: 55 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Hip Fractures

Intervention(s)

Drug: Saline

Drug: Bupivacaine

Primary Outcome(s)

Success rate of successful analgesia [Time Frame: 20 minutes]

Secondary Outcome(s)

Success rate of possible sonographic visualization [Time Frame: Expected average of 5 minutes]

Time to analgesia [Time Frame: 20 minutes]

Time used for the procedure [Time Frame: Expected average of 5 minutes]

Secondary ID(s)

protocol2tdn

Source(s) of Monetary Support

Please refer to primary and secondary sponsors